Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biphenylalanine is an unnatural (non-standard) hydrophobic amino acid that serves as a crucial building block in the design and synthesis of various peptides and small molecules with therapeutic potential. Its incorporation often enhances properties such as cellular uptake, membrane interaction, and specific binding affinities. It has been utilized in the development of antimicrobial peptides, inhibitors for enzymes like plasmin and histone demethylase KDM4A, antagonists for integrins, and components for targeting cancer cells and cardiomyocytes. Additionally, it plays a significant role in genetic code expansion technologies, allowing for the site-specific incorporation of non-standard amino acids into proteins for research and biomanufacturing applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Biphenylalanine.